Literature DB >> 27034342

Development of a consensus reverse transcription PCR assay for the specific detection of tortoise picornaviruses.

Rachel E Marschang1, Katalin Ihász1, Renáta Kugler1, György Lengyel1, Enikő Fehér1, Szilvia Marton1, Krisztián Bányai1, Tara Aqrawi1, Szilvia L Farkas2.   

Abstract

Picornaviruses (PVs) of different terrestrial tortoise species, previously designated as Virus "X," have been frequently detected from various tissues by virus isolation in Terrapene heart cell culture as the preferred laboratory method for diagnosis. Here, we describe the development of 2 diagnostic reverse transcription (RT)-PCR-based assays for the identification and characterization of tortoise PVs belonging to the tentative genus Topivirus To test the novel diagnostic systems, PVs were isolated from swab and tissue samples collected in Germany, Italy, and Hungary between 2000 and 2013. All 25 tested isolates gave positive results with both novel consensus primer sets. Sequencing of the amplified products confirmed that all studied viruses were members of the new proposed genus Topivirus Phylogenetic analyses clearly distinguished 2 lineages within the genus. Based on sequence analysis, no association was observed between the geographic distribution and genetic relatedness. Furthermore, no strict host specificity was indicated. The PCR-based diagnosis may provide a time-saving and sensitive method to detect tortoise PVs, and evaluation of PV presence in these animals may help control virus spread.
© 2016 The Author(s).

Entities:  

Keywords:  Diagnostic reverse transcription PCR assay; Terrapene heart cell; Testudo graeca; Topivirus

Mesh:

Substances:

Year:  2016        PMID: 27034342     DOI: 10.1177/1040638716628584

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  1 in total

1.  The role of Virus "X" (Tortoise Picornavirus) in kidney disease and shell weakness syndrome in European tortoise species determined by experimental infection.

Authors:  S Paries; S Funcke; O Kershaw; K Failing; M Lierz
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.